The full content of Annals is available to subscribers

Subscribe/Learn More  >
Editorials |

Is It Time To Proactively Switch Successful Antiretroviral Therapy? Carefully Check Your SWATCH

Michael Saag, MD
[+] Article, Author, and Disclosure Information

From University of Alabama at Birmingham; Birmingham, AL 35294.

Potential Financial Conflicts of Interest:Consultancies: Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffman-LaRoche, OrthoBiotech/Johnson & Johnson, Pfizer/Agouron, Schering-Plough, Shire Pharmaceutical, TherapyEdge, Tibotec/Virco, Trimeris, Virologic; Grants received: Abbott, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Hoffman-LaRoche, Ortho Biotech/Johnson & Johnson, Pfizer/Agouron, Pharmacia & Upjohn, Triangle Pharmaceuticals.

Requests for Single Reprints: Michael Saag, MD, University of Alabama at Birmingham, CCB Room 178, 908 20th Street South, Birmingham, AL 35294.

Ann Intern Med. 2003;139(2):148-149. doi:10.7326/0003-4819-139-2-200307150-00014
Text Size: A A A

The routine use of triple-drug antiretroviral therapy in the mid-1990s heralded the beginning of the highly active antiretroviral therapy (HAART) era in HIV therapeutics. With these potent regimens, viral replication in lymphatic tissue could be reduced almost completely, leading to levels of virus in plasma below assay detection limits (<50 copies/mL). This resulted in steady increases in CD4 cell counts, reductions in opportunistic infections, and a dramatic reduction in HIV-related mortality rates.

First Page Preview

View Large
First page PDF preview





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $32.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Topic Collections
PubMed Articles
Progress lies in precision. Science 2016;353(6301):731.
Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy. Curr HIV/AIDS Rep Published online Aug 25, 2016;
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.